scholarly journals Multiple myeloma derived from a kidney transplant donor who also developed myeloma after kidney donation

2019 ◽  
Vol 19 (8) ◽  
pp. 2374-2377 ◽  
Author(s):  
Shin-ichiro Fujiwara ◽  
Takashi Ikeda ◽  
Kaoru Morita ◽  
Takahiro Shinzato ◽  
Nobuo Ishikawa ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Kidney Transplant ◽  
Kidney Donation ◽  
Kidney Transplant Donor

scholarly journals Kidney Transplant Outcomes of Patients With Multiple Myeloma

2022 ◽  
Author(s):  
Cihan Heybeli ◽  
Andrew J. Bentall ◽  
Mariam Priya Alexander ◽  
Hatem Amer ◽  
Francis K. Buadi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Kidney Transplant ◽  
Transplant Outcomes

scholarly journals DNAJB11-Related Atypical ADPKD in a Kidney Transplant Donor

2020 ◽  
Vol 5 (8) ◽  
pp. 1363-1366
Author(s):  
Gregory J. Wilson ◽  
Simon Wood ◽  
Chirag Patel ◽  
Kimberley Oliver ◽  
George John ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Kidney Transplant Donor

Kidney transplant in multiple myeloma, the challenges, and potentials

2020 ◽  
Vol 4 (1-2) ◽  
pp. 15-17
Author(s):  
Nelson Leung
Keyword(s):  
Multiple Myeloma ◽  
Overall Survival ◽  
Kidney Transplantation ◽  
Kidney Transplant ◽  
Kidney Failure ◽  
Residual Disease ◽  
Graft Loss ◽  
Disease Assessment ◽  
Improve Patient Selection ◽  
Pros And Cons

Kidney failure is a common sequela of multiple myeloma. Tremendous progress in this disease over the past two decades has resulted in more than doubling of the median survival. Despite that, patients with irreversible kidney failure still have inferior outcomes as compared to those with intact kidney function. Kidney transplantation in these patients remains controversial. In this issue of Journal of Onco-Nephrology, two groups of clinicians caring for these patients debate the pros and cons of kidney transplantation in this population. The improvement of overall survival to 7.7 years in patients under the age of 65 years is a strong arg for kidney transplantation. In addition, the use of fluorescent in situ hybridization in risk assessment and minimal residual disease assessment for hematologic response could substantially improve patient selection for kidney transplantation. On the other hand, myeloma remains incurable and kidney failure itself is a high-risk feature. Despite advances, kidney transplantation in myeloma patients continues to present challenges with multiple myeloma relapse, rejection, and infection resulting in higher number of graft loss and death. Whether kidney transplant should be performed in patients with multiple myeloma currently remains debatable, but it may not be long before overall survival and disease control improve to the point where withholding kidney transplantation would be unethical. The questions in preparation for that day are should myeloma patients be held to the same metrics as patients without myeloma and if no, then what would be an acceptable overall and graft survival? Once the answers have been agreed upon by the experts and the governing bodies for transplantation, then proper clinical trials can be designed so that benefits can be optimized and precious resources not be wasted.

scholarly journals Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma

2018 ◽  
Vol 102 (12) ◽  
pp. 1994-2001 ◽  
Author(s):  
Janna L. Huskey ◽  
Raymond L. Heilman ◽  
Hasan Khamash ◽  
Rafael Fonseca
Keyword(s):  
Multiple Myeloma ◽  
Kidney Transplant

Renal Cell Carcinoma Detected by Preoperative Kidney Transplant Donor Examination: A Case Report

2014 ◽  
Vol 46 (2) ◽  
pp. 634-636
Author(s):  
T. Sato ◽  
Takahiro Yoneyama ◽  
K. Hagiwara ◽  
T. Narita ◽  
D. Noro ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Kidney Transplant ◽  
Renal Cell ◽  
Kidney Transplant Donor

Kidney Donation Withdrawal and Related Factors Among the Potential Donors of Living Kidney Transplant

2020 ◽  
Vol 52 (1) ◽  
pp. 73-77
Author(s):  
Kuan-Lin Liu ◽  
Hsu-Han Wang ◽  
Chin-Yi Hsieh ◽  
Xuan-Yi Huang ◽  
Chih-Te Lin ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Kidney Donation ◽  
Related Factors

APOL1 -Associated End-Stage Renal Disease in a Living Kidney Transplant Donor

2016 ◽  
Vol 16 (12) ◽  
pp. 3568-3572 ◽  
Author(s):  
N. A. Zwang ◽  
A. Shetty ◽  
N. Sustento-Reodica ◽  
E. J. Gordon ◽  
J. Leventhal ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
Kidney Transplant Donor

A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes

2021 ◽  
Author(s):  
Kaitlyn Dykes ◽  
Sameer Desale ◽  
Javaid Basit ◽  
Krystsina Miatlovich ◽  
Craig Kessler
Keyword(s):  
Multiple Myeloma ◽  
Renal Failure ◽  
Kidney Transplant ◽  
Transplant Outcomes
Sign in / Sign up

Export Citation Format

Share Document